 | • レポートコード：MMG23DC12344 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英語、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User（1名様閲覧用） | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Multi User（20名様閲覧用） | ￥625,300 (USD4,225) | ▷ お問い合わせ |
| Enterprise User（閲覧人数制限なし） | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の製剤CDMOサービス市場規模と予測を収録しています。・世界の製剤CDMOサービス市場：売上、2018年-2023年、2024年-2029年 ・世界の製剤CDMOサービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の製剤CDMOサービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「低分子CDMO」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 製剤CDMOサービスのグローバル主要企業は、Medicilon、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Jiuzhou Pharmaceutical、 Sinopep、 Frontier Biotechnologies、 JYMed、 Chengdu Shengnuo Biotechnology、 Shanghai Soho-Yiming Pharmaceuticals、 Chinese Peptide Company、 Ambio Pharmaceuticals、 Zhejiang Peptites Biotech、 STA Pharmaceutical、 Zhejiang Langhua Pharmaceutical、 Viva Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、製剤CDMOサービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の製剤CDMOサービス市場：タイプ別、2018年-2023年、2024年-2029年 世界の製剤CDMOサービス市場：タイプ別市場シェア、2022年 ・低分子CDMO、高分子CDMO 世界の製剤CDMOサービス市場：用途別、2018年-2023年、2024年-2029年 世界の製剤CDMOサービス市場：用途別市場シェア、2022年 ・臨床、商業生産 世界の製剤CDMOサービス市場：地域・国別、2018年-2023年、2024年-2029年 世界の製剤CDMOサービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における製剤CDMOサービスのグローバル売上、2018年-2023年 ・主要企業における製剤CDMOサービスのグローバル売上シェア、2022年 ・主要企業における製剤CDMOサービスのグローバル販売量、2018年-2023年 ・主要企業における製剤CDMOサービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medicilon、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Jiuzhou Pharmaceutical、 Sinopep、 Frontier Biotechnologies、 JYMed、 Chengdu Shengnuo Biotechnology、 Shanghai Soho-Yiming Pharmaceuticals、 Chinese Peptide Company、 Ambio Pharmaceuticals、 Zhejiang Peptites Biotech、 STA Pharmaceutical、 Zhejiang Langhua Pharmaceutical、 Viva Biotech ************************************************************* ・調査・分析レポートの概要 製剤CDMOサービス市場の定義 市場セグメント 世界の製剤CDMOサービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の製剤CDMOサービス市場規模 世界の製剤CDMOサービス市場規模：2022年 VS 2029年 世界の製剤CDMOサービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの製剤CDMOサービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の製剤CDMOサービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：低分子CDMO、高分子CDMO 製剤CDMOサービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：臨床、商業生産 製剤CDMOサービスの用途別グローバル売上・予測 ・地域別市場分析 地域別製剤CDMOサービス市場規模 2022年と2029年 地域別製剤CDMOサービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medicilon、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Jiuzhou Pharmaceutical、 Sinopep、 Frontier Biotechnologies、 JYMed、 Chengdu Shengnuo Biotechnology、 Shanghai Soho-Yiming Pharmaceuticals、 Chinese Peptide Company、 Ambio Pharmaceuticals、 Zhejiang Peptites Biotech、 STA Pharmaceutical、 Zhejiang Langhua Pharmaceutical、 Viva Biotech ... |
This research report provides a comprehensive analysis of the Formulation CDMO Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Formulation CDMO Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Formulation CDMO Services, challenges faced by the industry, and potential opportunities for market players.
The global Formulation CDMO Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Formulation CDMO Services market presents opportunities for various stakeholders, including Clinical Application, Commercial Production. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Formulation CDMO Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global Formulation CDMO Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Formulation CDMO services usually include the following services: formulation development, technology transfer, preparation of prescriptions, process standards, mass production, quality control and analysis, and registration support. Through the preparation CDMO service, the development and manufacture of preparations can be entrusted to professional institutions, thereby reducing their own R&D and production costs, and can speed up the process of launching products with the help of the experience and facilities of CDMO institutions. At the same time, the preparation CDMO service can also help customers ensure the quality, safety and regulatory compliance of preparation products, and improve the market competitiveness of products.
Key Features:
The research report on the Formulation CDMO Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Formulation CDMO Services market.
Market Overview: The report provides a comprehensive overview of the Formulation CDMO Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small Molecule CDMO, Macro-molecular CDMO), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Formulation CDMO Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Formulation CDMO Services market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Formulation CDMO Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Formulation CDMO Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Formulation CDMO Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Formulation CDMO Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Formulation CDMO Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Formulation CDMO Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Formulation CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small Molecule CDMO
Macro-molecular CDMO
Market segment by Application
Clinical Application
Commercial Production
Global Formulation CDMO Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Zhejiang Langhua Pharmaceutical
Viva Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Formulation CDMO Services, market overview.
Chapter 2: Global Formulation CDMO Services market size in revenue.
Chapter 3: Detailed analysis of Formulation CDMO Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Formulation CDMO Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Formulation CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Formulation CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Formulation CDMO Services Overall Market Size
2.1 Global Formulation CDMO Services Market Size: 2022 VS 2029
2.2 Global Formulation CDMO Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Formulation CDMO Services Players in Global Market
3.2 Top Global Formulation CDMO Services Companies Ranked by Revenue
3.3 Global Formulation CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Formulation CDMO Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Formulation CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Formulation CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Formulation CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Formulation CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Formulation CDMO Services Market Size Markets, 2022 & 2029
4.1.2 Small Molecule CDMO
4.1.3 Macro-molecular CDMO
4.2 By Type – Global Formulation CDMO Services Revenue & Forecasts
4.2.1 By Type – Global Formulation CDMO Services Revenue, 2018-2023
4.2.2 By Type – Global Formulation CDMO Services Revenue, 2024-2029
4.2.3 By Type – Global Formulation CDMO Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Formulation CDMO Services Market Size, 2022 & 2029
5.1.2 Clinical Application
5.1.3 Commercial Production
5.2 By Application – Global Formulation CDMO Services Revenue & Forecasts
5.2.1 By Application – Global Formulation CDMO Services Revenue, 2018-2023
5.2.2 By Application – Global Formulation CDMO Services Revenue, 2024-2029
5.2.3 By Application – Global Formulation CDMO Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Formulation CDMO Services Market Size, 2022 & 2029
6.2 By Region – Global Formulation CDMO Services Revenue & Forecasts
6.2.1 By Region – Global Formulation CDMO Services Revenue, 2018-2023
6.2.2 By Region – Global Formulation CDMO Services Revenue, 2024-2029
6.2.3 By Region – Global Formulation CDMO Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Formulation CDMO Services Revenue, 2018-2029
6.3.2 US Formulation CDMO Services Market Size, 2018-2029
6.3.3 Canada Formulation CDMO Services Market Size, 2018-2029
6.3.4 Mexico Formulation CDMO Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Formulation CDMO Services Revenue, 2018-2029
6.4.2 Germany Formulation CDMO Services Market Size, 2018-2029
6.4.3 France Formulation CDMO Services Market Size, 2018-2029
6.4.4 U.K. Formulation CDMO Services Market Size, 2018-2029
6.4.5 Italy Formulation CDMO Services Market Size, 2018-2029
6.4.6 Russia Formulation CDMO Services Market Size, 2018-2029
6.4.7 Nordic Countries Formulation CDMO Services Market Size, 2018-2029
6.4.8 Benelux Formulation CDMO Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Formulation CDMO Services Revenue, 2018-2029
6.5.2 China Formulation CDMO Services Market Size, 2018-2029
6.5.3 Japan Formulation CDMO Services Market Size, 2018-2029
6.5.4 South Korea Formulation CDMO Services Market Size, 2018-2029
6.5.5 Southeast Asia Formulation CDMO Services Market Size, 2018-2029
6.5.6 India Formulation CDMO Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Formulation CDMO Services Revenue, 2018-2029
6.6.2 Brazil Formulation CDMO Services Market Size, 2018-2029
6.6.3 Argentina Formulation CDMO Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Formulation CDMO Services Revenue, 2018-2029
6.7.2 Turkey Formulation CDMO Services Market Size, 2018-2029
6.7.3 Israel Formulation CDMO Services Market Size, 2018-2029
6.7.4 Saudi Arabia Formulation CDMO Services Market Size, 2018-2029
6.7.5 UAE Formulation CDMO Services Market Size, 2018-2029
7 Formulation CDMO Services Companies Profiles
7.1 Medicilon
7.1.1 Medicilon Company Summary
7.1.2 Medicilon Business Overview
7.1.3 Medicilon Formulation CDMO Services Major Product Offerings
7.1.4 Medicilon Formulation CDMO Services Revenue in Global Market (2018-2023)
7.1.5 Medicilon Key News & Latest Developments
7.2 Gliead
7.2.1 Gliead Company Summary
7.2.2 Gliead Business Overview
7.2.3 Gliead Formulation CDMO Services Major Product Offerings
7.2.4 Gliead Formulation CDMO Services Revenue in Global Market (2018-2023)
7.2.5 Gliead Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Formulation CDMO Services Major Product Offerings
7.3.4 Boehringer Ingelheim Formulation CDMO Services Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Vertex
7.4.1 Vertex Company Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex Formulation CDMO Services Major Product Offerings
7.4.4 Vertex Formulation CDMO Services Revenue in Global Market (2018-2023)
7.4.5 Vertex Key News & Latest Developments
7.5 Mirati Therapeutics
7.5.1 Mirati Therapeutics Company Summary
7.5.2 Mirati Therapeutics Business Overview
7.5.3 Mirati Therapeutics Formulation CDMO Services Major Product Offerings
7.5.4 Mirati Therapeutics Formulation CDMO Services Revenue in Global Market (2018-2023)
7.5.5 Mirati Therapeutics Key News & Latest Developments
7.6 AMPAC
7.6.1 AMPAC Company Summary
7.6.2 AMPAC Business Overview
7.6.3 AMPAC Formulation CDMO Services Major Product Offerings
7.6.4 AMPAC Formulation CDMO Services Revenue in Global Market (2018-2023)
7.6.5 AMPAC Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Formulation CDMO Services Major Product Offerings
7.7.4 Pfizer Formulation CDMO Services Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Polypeptide
7.8.1 Polypeptide Company Summary
7.8.2 Polypeptide Business Overview
7.8.3 Polypeptide Formulation CDMO Services Major Product Offerings
7.8.4 Polypeptide Formulation CDMO Services Revenue in Global Market (2018-2023)
7.8.5 Polypeptide Key News & Latest Developments
7.9 Bachem
7.9.1 Bachem Company Summary
7.9.2 Bachem Business Overview
7.9.3 Bachem Formulation CDMO Services Major Product Offerings
7.9.4 Bachem Formulation CDMO Services Revenue in Global Market (2018-2023)
7.9.5 Bachem Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Formulation CDMO Services Major Product Offerings
7.10.4 Merck Formulation CDMO Services Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Asymchem
7.11.1 Asymchem Company Summary
7.11.2 Asymchem Business Overview
7.11.3 Asymchem Formulation CDMO Services Major Product Offerings
7.11.4 Asymchem Formulation CDMO Services Revenue in Global Market (2018-2023)
7.11.5 Asymchem Key News & Latest Developments
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Company Summary
7.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.12.3 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Major Product Offerings
7.12.4 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue in Global Market (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
7.13 Sinopep
7.13.1 Sinopep Company Summary
7.13.2 Sinopep Business Overview
7.13.3 Sinopep Formulation CDMO Services Major Product Offerings
7.13.4 Sinopep Formulation CDMO Services Revenue in Global Market (2018-2023)
7.13.5 Sinopep Key News & Latest Developments
7.14 Frontier Biotechnologies
7.14.1 Frontier Biotechnologies Company Summary
7.14.2 Frontier Biotechnologies Business Overview
7.14.3 Frontier Biotechnologies Formulation CDMO Services Major Product Offerings
7.14.4 Frontier Biotechnologies Formulation CDMO Services Revenue in Global Market (2018-2023)
7.14.5 Frontier Biotechnologies Key News & Latest Developments
7.15 JYMed
7.15.1 JYMed Company Summary
7.15.2 JYMed Business Overview
7.15.3 JYMed Formulation CDMO Services Major Product Offerings
7.15.4 JYMed Formulation CDMO Services Revenue in Global Market (2018-2023)
7.15.5 JYMed Key News & Latest Developments
7.16 Chengdu Shengnuo Biotechnology
7.16.1 Chengdu Shengnuo Biotechnology Company Summary
7.16.2 Chengdu Shengnuo Biotechnology Business Overview
7.16.3 Chengdu Shengnuo Biotechnology Formulation CDMO Services Major Product Offerings
7.16.4 Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue in Global Market (2018-2023)
7.16.5 Chengdu Shengnuo Biotechnology Key News & Latest Developments
7.17 Shanghai Soho-Yiming Pharmaceuticals
7.17.1 Shanghai Soho-Yiming Pharmaceuticals Company Summary
7.17.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
7.17.3 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Major Product Offerings
7.17.4 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue in Global Market (2018-2023)
7.17.5 Shanghai Soho-Yiming Pharmaceuticals Key News & Latest Developments
7.18 Chinese Peptide Company
7.18.1 Chinese Peptide Company Company Summary
7.18.2 Chinese Peptide Company Business Overview
7.18.3 Chinese Peptide Company Formulation CDMO Services Major Product Offerings
7.18.4 Chinese Peptide Company Formulation CDMO Services Revenue in Global Market (2018-2023)
7.18.5 Chinese Peptide Company Key News & Latest Developments
7.19 Ambio Pharmaceuticals
7.19.1 Ambio Pharmaceuticals Company Summary
7.19.2 Ambio Pharmaceuticals Business Overview
7.19.3 Ambio Pharmaceuticals Formulation CDMO Services Major Product Offerings
7.19.4 Ambio Pharmaceuticals Formulation CDMO Services Revenue in Global Market (2018-2023)
7.19.5 Ambio Pharmaceuticals Key News & Latest Developments
7.20 Zhejiang Peptites Biotech
7.20.1 Zhejiang Peptites Biotech Company Summary
7.20.2 Zhejiang Peptites Biotech Business Overview
7.20.3 Zhejiang Peptites Biotech Formulation CDMO Services Major Product Offerings
7.20.4 Zhejiang Peptites Biotech Formulation CDMO Services Revenue in Global Market (2018-2023)
7.20.5 Zhejiang Peptites Biotech Key News & Latest Developments
7.21 STA Pharmaceutical
7.21.1 STA Pharmaceutical Company Summary
7.21.2 STA Pharmaceutical Business Overview
7.21.3 STA Pharmaceutical Formulation CDMO Services Major Product Offerings
7.21.4 STA Pharmaceutical Formulation CDMO Services Revenue in Global Market (2018-2023)
7.21.5 STA Pharmaceutical Key News & Latest Developments
7.22 Zhejiang Langhua Pharmaceutical
7.22.1 Zhejiang Langhua Pharmaceutical Company Summary
7.22.2 Zhejiang Langhua Pharmaceutical Business Overview
7.22.3 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Major Product Offerings
7.22.4 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue in Global Market (2018-2023)
7.22.5 Zhejiang Langhua Pharmaceutical Key News & Latest Developments
7.23 Viva Biotech
7.23.1 Viva Biotech Company Summary
7.23.2 Viva Biotech Business Overview
7.23.3 Viva Biotech Formulation CDMO Services Major Product Offerings
7.23.4 Viva Biotech Formulation CDMO Services Revenue in Global Market (2018-2023)
7.23.5 Viva Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Formulation CDMO Services Market Opportunities & Trends in Global Market
Table 2. Formulation CDMO Services Market Drivers in Global Market
Table 3. Formulation CDMO Services Market Restraints in Global Market
Table 4. Key Players of Formulation CDMO Services in Global Market
Table 5. Top Formulation CDMO Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Formulation CDMO Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Formulation CDMO Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Formulation CDMO Services Product Type
Table 9. List of Global Tier 1 Formulation CDMO Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Formulation CDMO Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Formulation CDMO Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Formulation CDMO Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Formulation CDMO Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Formulation CDMO Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Formulation CDMO Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Formulation CDMO Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Formulation CDMO Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Formulation CDMO Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Formulation CDMO Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Formulation CDMO Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Formulation CDMO Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Formulation CDMO Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Formulation CDMO Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Formulation CDMO Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Formulation CDMO Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Formulation CDMO Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Formulation CDMO Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Formulation CDMO Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Formulation CDMO Services Revenue, (US$, Mn), 2024-2029
Table 30. Medicilon Company Summary
Table 31. Medicilon Formulation CDMO Services Product Offerings
Table 32. Medicilon Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 33. Medicilon Key News & Latest Developments
Table 34. Gliead Company Summary
Table 35. Gliead Formulation CDMO Services Product Offerings
Table 36. Gliead Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 37. Gliead Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Formulation CDMO Services Product Offerings
Table 40. Boehringer Ingelheim Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Vertex Company Summary
Table 43. Vertex Formulation CDMO Services Product Offerings
Table 44. Vertex Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 45. Vertex Key News & Latest Developments
Table 46. Mirati Therapeutics Company Summary
Table 47. Mirati Therapeutics Formulation CDMO Services Product Offerings
Table 48. Mirati Therapeutics Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 49. Mirati Therapeutics Key News & Latest Developments
Table 50. AMPAC Company Summary
Table 51. AMPAC Formulation CDMO Services Product Offerings
Table 52. AMPAC Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 53. AMPAC Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Formulation CDMO Services Product Offerings
Table 56. Pfizer Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Polypeptide Company Summary
Table 59. Polypeptide Formulation CDMO Services Product Offerings
Table 60. Polypeptide Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 61. Polypeptide Key News & Latest Developments
Table 62. Bachem Company Summary
Table 63. Bachem Formulation CDMO Services Product Offerings
Table 64. Bachem Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 65. Bachem Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Formulation CDMO Services Product Offerings
Table 68. Merck Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. Asymchem Company Summary
Table 71. Asymchem Formulation CDMO Services Product Offerings
Table 72. Asymchem Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 73. Asymchem Key News & Latest Developments
Table 74. Zhejiang Jiuzhou Pharmaceutical Company Summary
Table 75. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Product Offerings
Table 76. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 77. Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
Table 78. Sinopep Company Summary
Table 79. Sinopep Formulation CDMO Services Product Offerings
Table 80. Sinopep Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 81. Sinopep Key News & Latest Developments
Table 82. Frontier Biotechnologies Company Summary
Table 83. Frontier Biotechnologies Formulation CDMO Services Product Offerings
Table 84. Frontier Biotechnologies Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 85. Frontier Biotechnologies Key News & Latest Developments
Table 86. JYMed Company Summary
Table 87. JYMed Formulation CDMO Services Product Offerings
Table 88. JYMed Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 89. JYMed Key News & Latest Developments
Table 90. Chengdu Shengnuo Biotechnology Company Summary
Table 91. Chengdu Shengnuo Biotechnology Formulation CDMO Services Product Offerings
Table 92. Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 93. Chengdu Shengnuo Biotechnology Key News & Latest Developments
Table 94. Shanghai Soho-Yiming Pharmaceuticals Company Summary
Table 95. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Product Offerings
Table 96. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 97. Shanghai Soho-Yiming Pharmaceuticals Key News & Latest Developments
Table 98. Chinese Peptide Company Company Summary
Table 99. Chinese Peptide Company Formulation CDMO Services Product Offerings
Table 100. Chinese Peptide Company Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 101. Chinese Peptide Company Key News & Latest Developments
Table 102. Ambio Pharmaceuticals Company Summary
Table 103. Ambio Pharmaceuticals Formulation CDMO Services Product Offerings
Table 104. Ambio Pharmaceuticals Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 105. Ambio Pharmaceuticals Key News & Latest Developments
Table 106. Zhejiang Peptites Biotech Company Summary
Table 107. Zhejiang Peptites Biotech Formulation CDMO Services Product Offerings
Table 108. Zhejiang Peptites Biotech Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 109. Zhejiang Peptites Biotech Key News & Latest Developments
Table 110. STA Pharmaceutical Company Summary
Table 111. STA Pharmaceutical Formulation CDMO Services Product Offerings
Table 112. STA Pharmaceutical Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 113. STA Pharmaceutical Key News & Latest Developments
Table 114. Zhejiang Langhua Pharmaceutical Company Summary
Table 115. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Product Offerings
Table 116. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 117. Zhejiang Langhua Pharmaceutical Key News & Latest Developments
Table 118. Viva Biotech Company Summary
Table 119. Viva Biotech Formulation CDMO Services Product Offerings
Table 120. Viva Biotech Formulation CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 121. Viva Biotech Key News & Latest Developments
List of Figures
Figure 1. Formulation CDMO Services Segment by Type in 2022
Figure 2. Formulation CDMO Services Segment by Application in 2022
Figure 3. Global Formulation CDMO Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Formulation CDMO Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Formulation CDMO Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Formulation CDMO Services Revenue in 2022
Figure 8. By Type - Global Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Formulation CDMO Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Formulation CDMO Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 16. US Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 20. Germany Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 28. China Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 34. Brazil Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Formulation CDMO Services Revenue Market Share, 2018-2029
Figure 37. Turkey Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Formulation CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 41. Medicilon Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gliead Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Vertex Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Mirati Therapeutics Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AMPAC Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Polypeptide Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bachem Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Asymchem Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sinopep Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Frontier Biotechnologies Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. JYMed Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Chinese Peptide Company Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Ambio Pharmaceuticals Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Zhejiang Peptites Biotech Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. STA Pharmaceutical Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Viva Biotech Formulation CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)